SPECIFIC AB1’ ANTIBODIES AGAINST TUMOUR-ASSOCIATED ANTIGEN CA 125
Application 1354/KOLNP/2004 published 2006-05-26, filed 2004-09-14
The present invention concerns specific anti-anti-idiotypic antibodies which react with anti-idiotypic antibodies which represent an internal image of the antigen CA125 and which also bind to the antigen itself i.e. are specific for the tumour associated antigen CA125. In particular the present invention concerns a CA125-specific anti-anti-idiotypic antibody which reacts with the anti-idiotypic antibody ACA125. In addition the present invention concerns pharmaceutical compositions containing these anti-anti-idiotypic antibodies for treating tumours that express CA125 and in particular ovarian carcinomas. (FIG). 1
Applicant
CELLCONTROL BIOMEDICAL LABORATORIES AG.,
LABORATORIES, AM KLOPFERSPITZ 19, 82152 MARTINSRIED, GERMANY.
Inventor
SCHLEBUSCH, HARALD WAGNER, UWE
International Info
Classification: C07K 16/42, 16/30, A61K 39/395, A61P 35/00
Publication Number: WO 03/076473
Application Date: 2003-03-07
Priority Information
102 10 239.2 GERMANY 2002-03-08